Dysphagia in Parkinson’s Disease

Dysphagia

Volumn 31, Issue 1, 2016, Pages 24-32

  Suttrup, Inga ^a   Warnecke, Tobias ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Diagnosis; Dysphagia; Parkinson s disease; Pathophysiology; Swallowing; Treatment

Indexed keywords

APOMORPHINE; LEVODOPA; ROTIGOTINE; SUBSTANCE P;

ASPIRATION PNEUMONIA; BRAIN DEPTH STIMULATION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE CLASSIFICATION; DISEASE COURSE; DOPAMINERGIC SYSTEM; DYSPHAGIA; DYSPHAGIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; EVIDENCE BASED MEDICINE; FIBERSCOPE ENDOSCOPY; FLUOROSCOPY; HOEHN AND YAHR SCALE; HUMAN; LEE SILVERMAN VOICE TREATMENT; MALNUTRITION; MANOMETRY; MORTALITY; MUNICH DYSPHAGIA TEST PARKINSON DISEASE; MUSCLE STRENGTH; MUSCLE TRAINING; NEUROLOGIC DISEASE ASSESSMENT; NEUROTRANSMISSION; NON MOTOR SYMPTOMS QUESTIONNAIRE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; REVIEW; SPEECH THERAPY; SWALLOWING; SWALLOWING DISTURBANCE QUESTIONNAIRE; UNIFIED PARKINSON DISEASE RATING SCALE; VIDEO ASSISTED SWALLOWING THERAPY; COMPLICATION; DEGLUTITION DISORDERS;

DEGLUTITION DISORDERS; HUMANS; PARKINSON DISEASE;

EID: 84958103298     PISSN: 0179051X     EISSN: 14320460     Source Type: Journal    
DOI: 10.1007/s00455-015-9671-9     Document Type: Review

References (98)

1. Pringsheim T, Jette N, Frolkis A, Steeves T. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.
2. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nation, 2005 through 2030. Neurology. 2007;68(5):384–6.
3. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones; 1817.
4. Kalf J, de Swart B, Bloem B, Munneke M. Prevalence of oropoharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18(4):311–5.
5. Miller N, Allcock L, Hildreth AJ, Jones D, Noble E, Burn DJ. Swallowing problems in Parkinson disease: frequency and clinical correlates. J Neurol Neurosurg Psychiatr. 2009;80(9):1047–9.
6. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg. 2008;16(3):205–10.
7. Edwards L, Quiglex EM, Hofmann R, Pfeiffer RF. Gastrointestinal symptoms in Parkinson’s disesase: 18-month-follow-up study. Mov Disord. 1993;8(1):83–6.
8. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptomes and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641–9.
9. Cereda E, Cilia R, Klersy C, et al. Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord. 2014;20(12):1382–7.
10. Müller J, Wenning GK, Verny J, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58(2):259–64.
11. Coelho M, Marti MJ, Tolosa E, et al. Late-stage Parkinson’s disease: the barcelona and lisbon cohort. J Neurol. 2010;257(9):1524–32.
12. Fuh J, Lee RC, Wang J, et al. Swallowing difficulty in Parkinson’s disease. Clin Neurol Neurosurg. 1997;99(2):106–12.
13. Noyce A, Silveira-Moriyama L, Gilpin P, Ling H, Howard R, Lees A. Severe dysphagia as a presentation of Parkinson’s disease. Mov Disord. 2012;27(3):457.
14. Thomas M, Haigh R. Dysphagia, a reversible cause not to be forgotten. Postgrad Med J. 1995;71(832):94–5.
15. Miller N, Noble E, Jones D, Burn D. Hard to swallow: dysphagia in Parkinson’s disease. Age Ageing. 2006;35(6):614–8.
16. Plowman-Prine EK, Sapienza CM, Okun MS, Pollock SL, Jacobson C, Wu SS, et al. The relationship between quality of life and swallowing in Parkinson’s disease. Mov Disord. 2009;24(9):1352–8.
17. Morgante L, Salemi G, Meneghini F, et al. Parkinson disease survival: a population-based study. Arch Neurol. 2000;57(4):507–12.
18. Lin CW, Chang YC, Chen WS, et al. Prolonged swallowing time in dysphagic Parkinsonism patients with aspiration pneumonia. Arch Phys Med Rehabil. 2012;93:2080–4.
19. Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14:625–39.
20. Manor Y, Balas M, Giladi N, Mootanah R, Cohen J. Anxiety, depression and swallowing disorders in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(6):453–6.
21. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
22. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
23. Suzuki M, Asada Y, Ito J, Hayashi K, Inoue H, Kitano H. Activation of cerebellum and basal ganglia on volitional swallowing detected by functional magnetic resonance imaging. Dysphagia. 2003;18(2):71–7.
24. Warnecke T, Hamacher C, Oelenberg S, Dziewas R. Off and on-state assessment of swallowing function in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):1033–4.
25. Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19(9):783–8.
26. Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197–211.
27. Hunter P, Crameri J, Austin S, Woodward M, Hughes A. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry. 1997;63(5):579–83.
28. Braak H, Del Tredici K, Bratzke H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol. 2002;249(Suppl 3):III1–5.
29. Suntrup S, Teismann I, Bejer J, Suttrup S, Winkels M, Mehler D, Pantev C, Dziewas R, Warnecke T. Evidence for adaptive cortical changes in swallowing in Parkinson’s disease. Brain. 2013;136(3):726–38.
30. Berg D, Lang AE, Posturma RB, et al. Changing the research criteria for the diagnosis of Parkinson’s disease: obstacles and opportunities. Lancet Neurol. 2013;12(5):514–24.
31. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases. Mov Disord. 2012;27(6):716–9.
32. Pan-Montojo F, Reichmann H. Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology. Transl Neurodegener. 2014;3:10.
33. Pan-Montojo F, Anichtchik O, Dening Y. Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE. 2010;5(1):e8762.
34. Pan-Montojo F, Schwarz M, Winkler C, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898.
35. Sung HY, Kim JS, Lee KS, et al. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson’s disesase. Mov Disord. 2010;25(14):2361–8.
36. Mu L, Sobotka S, Chen J, et al. Alpha-Synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson’s disease. J Neuropathol Exp Neurol. 2013;72(2):119–29.
37. Mu L, Sobotka S, Chen J, et al. Parkinson’s disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol. 2013;72(7):614–23.
38. Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson disease. Neuropathol Exp Neurol. 2012;71(6):520–30.
39. Ciucci MR, Russell AJ, Schaser AJ, et al. Tongue force and timing deficits in a rat model of Parkinson disease. Behav Brain Res. 2011;222(2):315–20.
40. Ciucci MR, Schaser AJ, Russell JA. Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease. Behav Brain Res. 2013;252:239–45.
41. Russell AJ, Ciucci MR, Hammer MJ, Connor NP. Videofluorographic assessment of deglutitive behaviors in a rat model of aging and Parkinson disease. Dysphagia. 2013;28(1):95–104.
42. Kane JR, Ciucci MR, Jacobs AN, et al. Asssessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson’s disease. J Commun Disord. 2011;44(5):529–37.
43. Fulceri F, Biagioni F, Lenzi P, et al. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures. Ann N Y Acad Sci. 2006;1074:344–8.
44. Tillerson JL, Cohen AD, Philhower J, et al. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci. 2001;21:4427–35.
45. Troche MS, Brandimore AE, Okun MS, Davenprot PW, Hegland KW. Decreased cough sensitivity and aspiration in Parkinson disease. Chest. 2014;146:1294–9.
46. Ebihara S, Saito H, Kanda A, Nakajoh M, Takahashi H, Arai H, Sasaki H. Impaired efficacy of cough in patients with Parkinson disease. Chest. 2003;124(3):1009–15.
47. Bird M, Woodward M, Gibson E, Phyland D, Fonda D. Asymptomatic swallowing disorders in elderly patients with Parkinson’s disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing. 1994;23(3):251–4.
48. Bushmann M, Dobmeyer S, Leeker L, Perlmutter J. Swallowing abnormalities and their responses to treatment in Parkinson’s disease. Neurology. 1989;39:1309–14.
49. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
50. Simons JA, Fietzek UM, Waldmann A, Warnecke T, Schuster T, Ceballos-Baumann AO. Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):992–8.
51. Manor Y, Giladi N, Cohen A, Fliss D, Cohen T. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease. Mov Disord. 2007;22(13):1917–21.
52. Evatt ML, Chaudhuri KR, Chou KL, et al. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia and constipation—critique and recommendations by Movement Disorders Task Force on rating scales for Parkinson’s disease. Mov Disord. 2009;24(5):635–46.
53. McHorney CA, Bricker DE, Kramer AE, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia. 2000;15:115–21.
54. McHorney CA, Robbins J, Lomax K, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97–114.
55. Chardhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptomes of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704–9.
56. Boot JA, Chaudhuri KR. Oropharyngeal dysphagia in Parkinson’s disease: comments on paper by Kalf et al. Parkinsonism Relat Disord. 2013;19(2):275.
57. Kalf JG, de Swart BJ, Munneke M, Bloem BR. Author reply to “Oropharyngeal dysphagia in Parkinson’s disease: comments on paper by Kalf et al.” by Boot and Chaudhuri. Parkinsonism Relat Disord. 2013;19(2):276.
58. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
59. Lam K, Lam FK, Lau KK, et al. Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson’s disease. Mov Disord. 2007;22(5):640–4.
60. Norbrega AC, Rodriguez B, Melo A. Silent aspiration in Parkinson’s disease patients with diurnal sialorrhea. Clin Neurol Neurosurg. 2008;110(2):117–9.
61. Kalf H, de Swart B, Bonnier-Baars M, Hofman M, Kanters J, Kocken J, Miltenburg M, Bloem BR, Munneke M. Guidelines for speech-language therapy in Parkinson’s disease. Nijmegen, the Netherlands/Miami (FL), U.S.A.: ParkinsonNet/NPF. Originally published in Dutch as Logopedie bij de ziekte van Parkinson. Een richtlijn van de Nederlandse Vereniging voor Logopedie en Foniatrie; 2008.
62. Ertekin C, Aydogdu I, Yuceyar N, et al. Electrodiagnostic methods for neurogenic dysphagia. Electroencephalogr Clin Neurophysiol. 1998;109(4):331–40.
63. Potulska A, Friedmann A, Krolicki L, et al. Swallowing disorders in Parkinson’s disease. Parkinsonism Relat Disord. 2003;9(6):349–53.
64. Nathadwarawala KM, McGroary A, Wiles CM. Swallowing in neurological outpatients: use of a timed test. Dysphagia Spring. 1994;9(2):120–9.
65. Clarke CE, Gullaksen E, Macdonald S, Lowe F. Referral criteria for speech and language therapy assessement of dysphagia caused by idiopathic Parkinson’s disease. Acta Neurol Scand. 1998;97(1):27–35.
66. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
67. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
68. Monte F, da Silva-Junior F, Braga-Neto P, Nobre e Sousa M, de Bruin V. Swallowing abnormalities and dyskinesia in Parkinson’s disease. Mov Disord. 2005;20(4):457–62.
69. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
70. Warnecke T, Ringelstein EB, Dziewas R. Neurologische endoskopische Dysphagiediagnostik—Untersuchungstechnik, Einsatzmöglichkeiten und typische Befunde. Klin Neurophysiol. 2009;40:194–203.
71. Logemann JA. Evaluation and treatment of swallowing disorders. 2nd ed. Austin: Pro-Ed; 1998.
72. Suttrup I, Suntrup S, Siemer ML, Bauer J, Hamacher C, Oelenberg S, Domagk D, Dziewas R, Warnecke T. Esophageal swallowing disorders in patients with different parkinsonian syndromes as detected by high resolution manometry. Dysphagia. 2014;29(1):121–81.
73. Warnecke T, Oelenberg S, Teismann I, Hamacher C, Lohmann H, Ringelstein RB, Dziewas R. Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. Mov Disord. 2010;25(9):1239–45.
74. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(1):10–5.
75. Castell JA, Johnston BT, Colcher A, Li Q, Gideon RM, Castell DO. Manometric abnormalities of the oesophagus in patients with Parkinson’s disease. Neurogastroenterol Motil. 2001;13(4):361–4.
76. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
77. Troche MS, Okun MS, Rosenbek JC, et al. Attentional resource allocation and swallowing safety in Parkinson’s disease: a duel task study. Parkinsonism Relat Disord. 2014;20(4):439–43.
78. Baijens L, Speyer R. Effects of therapy for dysphagia in Parkinson’s disease: a systematic review. Dysphagia. 2009;24(1):91–102.
79. Van Hooren MR, Baijens LW, Vaskuilen S, Oosterloo M, Kremer B. Treatment effects for dysphagia in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2014;20(8):800–7.
80. Troche MS, Okun MS, Rosenbek JC, et al. Aspiration and swallowing in Parkinson’s disease and rehabilitation with EMST: a randomized trial. Neurology. 2010;75(21):1912–9.
81. Troche MS, Rosenbek JC, Okun MS, Sapienza CM. Detraining outcomes with expiratory muscle strength training in Parkinson’s disease. J Rehabil Res Dev. 2014;51(2):305–10.
82. Manor Y, Mootanah R, Freud D, Giladi N, Cohen JT. Video-assisted swallowing therapy for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19(2):207–11.
83. El Sharkawi A, Ramig L, Logemann AJ, et al. Swallowing and voice effects of lee silverman voice treatmend (LSVT): a pilot study. J Neurol Neurosurg Psychiatry. 2002;72(1):31–6.
84. Sutton JP. Dysphagia in Parkinson’s disease is responsive to levodopa. Parkinsonism Relat Disord. 2013;19(3):282–4.
85. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–45.
86. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatr. 2008;79(4):368–76.
87. Suttrup I, Oelenberg S, Hamacher C, Dziewas R, Warnecke T. Endoscopic L-dopa-test for parkinsonian dysphagia (a pilot study). Dysphagia. 2011;26:482.
88. Lim A, Leow L, Huckabee M, et al. A pilot study of respiration and swallowing integration in Parkinson’s disease: ‘on’ and ‘off’ levodopa. Dysphagia. 2008;23:76–81.
89. Hirano M, Isono C, Sakamoto H, Ueno S, Kusunoki S, Nakamura Y. Rotigotine transdermal patch improves swallowing in dysphagic patients with Parkinson’s disesase. Dysphagia. 2015;30(4):452–6.
90. Muller B, Assmus J, Larsen J, Haugarvoll K, Skeie G, Tysnes O. Autonomic symptoms and dopaminergic treatment in de novo Parkinson’s disease. Acta Neurol Scand. 2013;127(4):294.
91. Lengerer S, Kipping J, Rommel N, et al. Deep brain stimulation does not impair deglutition in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:847–53.
92. Sunstedt S, Olofsson K, van Doorn J, et al. Swallowing function in Parkinson’s patients following zona incerta deep brain stimulation. Acta Neurol Scand. 2012;126:350–6.
93. Kulneff L, Sundstedt S, Olofsson K, et al. Deep brain stimulation-effects on swallowing function in Parkinson’s disease. Acta Neurol Scand. 2012;1:1–8.
94. Silbergleit AK, Lewitt P, Junn F, et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson’s disease. Mov Disord. 2012;27:1763–8.
95. Troche MS, Brandimore A, Foote K, et al. Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis. Dysphagia. 2014;29(4):425–31.
96. Ciucci MR, Brakmeier-Kraemer JM, Shermann SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov Disord. 2008;23(5):676–83.
97. Xie T, Vigil J, MacCracken E, et al. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015;84(4):415–20.
98. Derrey S, Chastan N, Maltete D, et al. Impact of deep brain stimulation on pharyngo-esophageal motility: a randomized cross-over study. Neurogastroenterol Motil. 2015;27:1214–22.